Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

31
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
31
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

809
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
809
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

413
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
413
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

746
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
746

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinician Obligations to Care for Patients Infected With Special Pathogens.

JAMA network open·2026
Same author

Quantitative Acid-Base: A Simplified Approach for the Emergency Physician.

The Journal of emergency medicine·2025
Same author

Blinking Bug Bite.

Clinical practice and cases in emergency medicine·2018
Same author

Disaster Training in 24 Hours: Evaluation of a Novel Medical Student Curriculum in Disaster Medicine.

The Journal of emergency medicine·2018
Same author

Thrombotic Microangiopathies (TTP, HUS, HELLP).

Hematology/oncology clinics of North America·2017
Same author

Abdominal Pain in the Immunocompromised Patient-Human Immunodeficiency Virus, Transplant, Cancer.

Emergency medicine clinics of North America·2016
Same journal

Why Dispelling Myths and Misconceptions in Emergency Medicine Matters.

Emergency medicine clinics of North America·2026
Same journal

Myths and Misconceptions in Emergency Medicine.

Emergency medicine clinics of North America·2026
Same journal

Acute Otitis Media-Watch and Wait Is Not a Myth.

Emergency medicine clinics of North America·2026
Same journal

Hot or Not? Myths and Misconceptions About Antipyretics for Pediatric Fever.

Emergency medicine clinics of North America·2026
Same journal

Epinephrine Improves Outcomes in Out-Of-Hospital Cardiac Arrests.

Emergency medicine clinics of North America·2026
Same journal

Myth: Pretreatment Prevents Intravenous Contrast Reactions in the Emergency Department.

Emergency medicine clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

382

Thrombotic microangiopathies (TTP, HUS, HELLP).

Shane Kappler1, Sarah Ronan-Bentle2, Autumn Graham1

  • 1Department of Emergency Medicine, Medstar Georgetown University Hospital, Washington Hospital Center, 3800 Reservoir Road, Northwest, Washington, DC 20007, USA.

Emergency Medicine Clinics of North America
|July 26, 2014
PubMed
Summary
This summary is machine-generated.

Thrombocytopenia, a low platelet count, requires prompt diagnosis and management in emergency settings. This review covers thrombotic microangiopathies like TTP and HUS, distinguishing them from other platelet disorders.

Keywords:
DICHELLPHUSHemolytic anemiaITPMicroangiopathiesTTPThrombocytopenia

More Related Videos

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

15.6K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.1K

Related Experiment Videos

Last Updated: Apr 26, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

382
Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

15.6K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.1K

Area of Science:

  • Hematology
  • Emergency Medicine
  • Pathophysiology

Background:

  • Thrombocytopenia (platelet count < 150,000/μL) is frequently encountered in emergency departments.
  • Prompt recognition and management are crucial for patient outcomes.
  • Thrombotic microangiopathies are a key cause of platelet destruction.

Purpose of the Study:

  • To provide a comprehensive overview of thrombotic microangiopathies.
  • To differentiate these conditions from other causes of thrombocytopenia.
  • To guide emergency department diagnosis and management.

Main Methods:

  • Literature review focusing on clinical presentations.
  • Pathophysiology, diagnostic workup, and management strategies.
  • Discussion of complications and patient disposition.

Main Results:

  • Thrombotic microangiopathies, including TTP, HUS, and HELLP syndrome, are characterized by platelet destruction.
  • Differential diagnosis includes ITP, DIC, and HIT.
  • Effective management requires accurate diagnostic workup.

Conclusions:

  • Thrombotic microangiopathies present unique diagnostic and management challenges in the ED.
  • Distinguishing TTP, HUS, and HELLP from other thrombocytopenic states is critical.
  • A systematic approach to diagnosis and disposition is essential.